.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Fuji
Citi
Johnson and Johnson
Chinese Patent Office
Dow
Boehringer Ingelheim
US Department of Justice
Argus Health
Cerilliant

Generated: November 18, 2017

DrugPatentWatch Database Preview

Erythromycin - Generic Drug Details

« Back to Dashboard

What are the generic sources for erythromycin and what is the scope of erythromycin patent protection?

Erythromycin
is the generic ingredient in fifty-two branded drugs marketed by Hi Tech Pharma, Taro, Altana, Merz Pharms, Mylan Pharms Inc, Paddock Llc, Dista, Perrigo Co, Arbor Pharms Llc, Akorn, Pharmafair, Parke Davis, Fougera Pharms, Dow Pharm, Wockhardt, Alpharma Us Pharms, Westwood Squibb, Renaissance Pharma, Barr, Lilly, Robins Ah, Mayne Pharma, Warner Chilcott Llc, Perrigo New York, Bausch And Lomb, Pharmaderm, Perrigo Co Tennessee, Ivax Sub Teva Pharms, Teligent Pharma Inc, Solvay, Syosset, Arbor Pharms Inc, Hospira, Johnson And Johnson, Life Labs, G And W Labs Inc, Watson Labs, Ross Labs, Wyeth Ayerst, Mylan, Ani Pharms Inc, Naska, Pharmacia And Upjohn, Alra, Abraxis Pharm, Teva Parenteral, Elkins Sinn, Abbott, Baxter Hlthcare, Bristol, Bristol Myers Squibb, Warner Chilcott, Purepac Pharm, Lederle, and Pfizer, and is included in one hundred and twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are ninety-nine drug master file entries for erythromycin. Thirty-seven suppliers are listed for this compound.

Pharmacology for erythromycin

Medical Subject Heading (MeSH) Categories for erythromycin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Arbor Pharms Llc
E.E.S.
erythromycin ethylsuccinate
GRANULE;ORAL050207-001Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe
Barr
ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL
erythromycin ethylsuccinate; sulfisoxazole acetyl
GRANULE;ORAL062759-001May 20, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Dow Pharm
SANSAC
erythromycin
SOLUTION;TOPICAL062522-001Jan 24, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
ERYTHROMYCIN ESTOLATE
erythromycin estolate
CAPSULE;ORAL062237-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Perrigo Co
ERYTHROMYCIN
erythromycin
SWAB;TOPICAL064126-001Jul 3, 1996ATRXNoYes► Subscribe► Subscribe► Subscribe
Lilly
ILOSONE
erythromycin estolate
SUSPENSION;ORAL061894-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmafair
ERYTHROMYCIN ETHYLSUCCINATE
erythromycin ethylsuccinate
SUSPENSION;ORAL062559-001Mar 15, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Arbor Pharms Llc
ERYTHROMYCIN
erythromycin
TABLET;ORAL061621-002Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe► Subscribe
Arbor Pharms Llc
ERYTHROCIN STEARATE
erythromycin stearate
TABLET;ORAL060359-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
ERYC 125
erythromycin
CAPSULE, DELAYED REL PELLETS;ORAL062648-001Oct 24, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
McKinsey
Colorcon
Cipla
Medtronic
Teva
US Department of Justice
Accenture
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot